Drug Companies Must Adapt to the 'Bioburst' Era

“Bioburst” as the name Richard Noel Re gives to the revolution now taking place in molecular biology. In his book Bioburst: The Impact of Modern Biology on the Affairs of Man (Louisiana State University Press, 1986), Re discusses how that revolution will permeate contemporary life. He uses the discovery of cyclosporin A to illustrate the new flexibility needed in the pharmaceutical industry to deal with this revolution. The excerpt below is taken from the book. Chance favors the

Written byRichard Noel Re
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

“Bioburst” as the name Richard Noel Re gives to the revolution now taking place in molecular biology. In his book Bioburst: The Impact of Modern Biology on the Affairs of Man (Louisiana State University Press, 1986), Re discusses how that revolution will permeate contemporary life. He uses the discovery of cyclosporin A to illustrate the new flexibility needed in the pharmaceutical industry to deal with this revolution. The excerpt below is taken from the book.

Chance favors the prepared mind, and this is nowhere more true than in the arcane world of molecular biology. The need for a staff well versed in all areas of biology has always existed in biomedical research, but the need is all the more acute now that so apparently great an intellectual gulf separates the old and the new biologies. That this schism is real can be readily seen by discussing the issue with the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies